These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 28668477)
1. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents. Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477 [TBL] [Abstract][Full Text] [Related]
2. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy. Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920 [TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties. Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583 [TBL] [Abstract][Full Text] [Related]
4. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity. Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251 [TBL] [Abstract][Full Text] [Related]
5. "Half-sandwich" Schiff-base Ir(III) complexes as anticancer agents. Mou ZD; Deng N; Zhang F; Zhang J; Cen J; Zhang X Eur J Med Chem; 2017 Sep; 138():72-82. PubMed ID: 28646657 [TBL] [Abstract][Full Text] [Related]
6. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands. Ludwig G; Mijatović S; Ranđelović I; Bulatović M; Miljković D; Maksimović-Ivanić D; Korb M; Lang H; Steinborn D; Kaluđerović GN Eur J Med Chem; 2013 Nov; 69():216-22. PubMed ID: 24042044 [TBL] [Abstract][Full Text] [Related]
7. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents. Li Y; Liu B; Lu XR; Li MF; Ji LN; Mao ZW Dalton Trans; 2017 Aug; 46(34):11363-11371. PubMed ID: 28812748 [TBL] [Abstract][Full Text] [Related]
8. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria. Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145 [TBL] [Abstract][Full Text] [Related]
9. Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies. Li J; Guo L; Tian Z; Zhang S; Xu Z; Han Y; Li R; Li Y; Liu Z Inorg Chem; 2018 Nov; 57(21):13552-13563. PubMed ID: 30289251 [TBL] [Abstract][Full Text] [Related]
10. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents. Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192 [TBL] [Abstract][Full Text] [Related]
11. Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents. Ye RR; Tan CP; Ji LN; Mao ZW Dalton Trans; 2016 Aug; 45(33):13042-51. PubMed ID: 27139504 [TBL] [Abstract][Full Text] [Related]
12. Ru(II) complexes bearing guanidinium ligands as potent anticancer agents. Chen WX; Song XD; He SF; Sun J; Chen JX; Wu T; Mao ZW J Inorg Biochem; 2016 Nov; 164():91-98. PubMed ID: 27666421 [TBL] [Abstract][Full Text] [Related]
13. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes. Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887 [TBL] [Abstract][Full Text] [Related]
15. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents. Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052 [TBL] [Abstract][Full Text] [Related]
16. Valproic Acid-Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents. Ye RR; Cao JJ; Tan CP; Ji LN; Mao ZW Chemistry; 2017 Oct; 23(60):15166-15176. PubMed ID: 28833658 [TBL] [Abstract][Full Text] [Related]
17. Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents. Li Y; Tan CP; Zhang W; He L; Ji LN; Mao ZW Biomaterials; 2015 Jan; 39():95-104. PubMed ID: 25477176 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands. Sun J; Chen WX; Song XD; He SF; Chen JX; Mei J; Zhu XX; Wu T Anticancer Agents Med Chem; 2018; 18(1):110-120. PubMed ID: 28425859 [TBL] [Abstract][Full Text] [Related]
19. Influence of substituents on DNA and protein binding of cyclometalated Ir(iii) complexes and anticancer activity. Mukhopadhyay S; Singh RS; Paitandi RP; Sharma G; Koch B; Pandey DS Dalton Trans; 2017 Jul; 46(26):8572-8585. PubMed ID: 28640302 [TBL] [Abstract][Full Text] [Related]
20. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents. Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]